ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,608,542 | -59.7% | 101,193 | -71.3% | 0.02% | -62.2% |
| Q1 2023 | $8,958,936 | +60.7% | 352,714 | +156.6% | 0.04% | +45.2% |
| Q4 2022 | $5,574,282 | +118.6% | 137,433 | +78.1% | 0.03% | +121.4% |
| Q3 2022 | $2,550,000 | -72.5% | 77,154 | -70.7% | 0.01% | -70.8% |
| Q2 2022 | $9,259,000 | +168.3% | 262,978 | +250.5% | 0.05% | +140.0% |
| Q1 2022 | $3,451,000 | +358.3% | 75,035 | +560.3% | 0.02% | +400.0% |
| Q4 2021 | $753,000 | -93.8% | 11,363 | -94.2% | 0.00% | -94.9% |
| Q3 2021 | $12,137,000 | -12.9% | 194,413 | +15.6% | 0.08% | -19.6% |
| Q2 2021 | $13,927,000 | -36.9% | 168,154 | -49.5% | 0.10% | -39.8% |
| Q1 2021 | $22,084,000 | +211.7% | 333,045 | +260.6% | 0.16% | +172.9% |
| Q4 2020 | $7,086,000 | +134.9% | 92,355 | -11.9% | 0.06% | -32.2% |
| Q1 2020 | $3,017,000 | -52.6% | 104,849 | +4.4% | 0.09% | -29.8% |
| Q4 2019 | $6,368,000 | +346.9% | 100,400 | +86.7% | 0.12% | +217.9% |
| Q2 2019 | $1,425,000 | -10.8% | 53,790 | -38.2% | 0.04% | -18.8% |
| Q1 2019 | $1,597,000 | – | 87,017 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |